Use of a program-specific website to disseminate data on antimicrobial susceptibility of clinical isolates from the Tigecycline Evaluation and Surveillance Trial (TEST);Le site internet TEST d'évaluation de l'activité de la tigécycline sur des isolats cliniques : un outil pratique pour obtenir des données de sensibilité actualisées

Medecine et Maladies Infectieuses

Volumn 38, Issue 3, 2008, Pages 133-140

  Leclercq, R ^a   Goulenok, C ^b   Loncle Provot, V ^c  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^c Wyeth Coeur Défense Tour A ^*  (France)

Author keywords

Antibiotic resistance; Antimicrobial susceptibility; Clinical isolates; Information dissemination; Internet; Microbial sensitivity tests; Population surveillance; Tigecycline

Indexed keywords

TIGECYCLINE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS; HEALTH PROGRAM; HEALTH SURVEY; INTERNET; MICROBIAL SENSITIVITY TEST; NONHUMAN; OUTCOME ASSESSMENT; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE; COMMUNICABLE DISEASE; COMPUTER PROGRAM; CROSS INFECTION; DRUG SCREENING; FACTUAL DATABASE; HEALTH; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; QUALITY CONTROL; SPECIES DIFFERENCE; STATISTICS;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DATA DISPLAY; DATABASES, FACTUAL; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFORMATION DISSEMINATION; INTERNET; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POPULATION SURVEILLANCE; QUALITY CONTROL; SOFTWARE; SPECIES SPECIFICITY; WORLD HEALTH;

EID: 43049110545     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2007.12.001     Document Type: Article

References (31)

1. Schito G.C., Debbia E.A., and Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother 46 Suppl T1 (2000) 3-9
2. Ramirez A. Controlling multiple-drug-resistant organisms at the hospital level. Expert Opin Pharmacother 7 (2006) 1449-1455
3. Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 Suppl 2 (2006) S82-S89
4. Lee S.Y., Kotapati S., Kuti J.L., et al. Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27 (2006) 1226-1232
5. Spellberg B., Powers J.H., Brass E.P., et al. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38 (2004) 1279-1286
6. Overbye K.M., and Barrett J.F. Antibiotics: where did we go wrong?. Drug Discov Today 10 (2005) 45-52
7. Sum P.E., Lee V.J., Testa R.T., et al. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J Med Chem 37 (1994) 184-188
8. Zhanel G.G., Homenuik K., Nichol K., et al. The glycylcyclines: a comparative review with the tetracyclines. Drugs 64 (2004) 63-88
9. Noskin G.A. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis 41 Suppl 5 (2005) S303-S314
10. Petersen P.J., Jacobus N.V., Weiss W.J., et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 43 (1999) 738-744
11. Jones R.N., and Masterton R. Determining the value of antimicrobial surveillance programs. Diagn Microbiol Infect Dis 41 (2001) 171-175
12. Masterton R.G. Surveillance studies: how can they help the management of infection?. J Antimicrob Chemother 46 Suppl T2 (2000) 53-58
13. Morris A.K., and Masterton R.G. Antibiotic resistance surveillance: action for international studies. J Antimicrob Chemother 49 (2002) 7-10
14. Burley C.J., and Tillotson G.S. Antimicrobial resistance: can we see the wood for the trees?. Lancet Infect Dis 3 (2003) 125-126
15. Livermore D.M., and Pearson A. Antibiotic resistance: location, location, location. Clin Microbiol Infect 13 Suppl 2 (2007) 7-16
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, document M7-A6 (2003), NCCLS
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing (2006), CLSI 16th informational supplement, document M100-S16
18. InVS R. État des lieux de la résistance bactérienne aux antibiotiques en France en 2003-2004 et tendances récentes. Disponible à http://www.invs.sante.fr/surveillance/resistance/synthese_ratb_avril2006.pdf. Avril 2006. 13 pages.
19. EARSS Annual report 2005. Disponible à : http://www.rivm.nl/earss/Images/EARSS%202005_tcm61-34899.pdf.
20. Masterton R., Drusano G., Paterson D.L., and Park G. Appropriate antimicrobial treatment in nosocomial infections-the clinical challenges. J Hosp Infect 55 Suppl 1 (2003) 1-12
21. Kollef M.H. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J Med 115 (2003) 582-584
22. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 31 Suppl 4 (2000) S131-S138
23. Carlet J., and Tabah A. Antibiothérapie des états infectieux graves. Med Mal Infect 36 (2006) 299-303
24. Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almodovar A., et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31 (2003) 2742-2751
25. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 63 (2003) 2157-2168
26. Kang C.I., Kim S.H., Park W.B., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49 (2005) 760-766
27. Carlet J., Ben Ali A., and Chalfine A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis 17 (2004) 309-316
28. Falagas M.E., and Karveli E.A. World Wide Web resources on antimicrobial resistance. Clin Infect Dis 43 (2006) 630-633
29. Harbarth S., and Emonet S. Navigating the World Wide Web in search of resources on antimicrobial resistance. Clin Infect Dis 43 (2006) 72-78
30. Mejicano G.C., and Wright M.O. Web resources for antimicrobial resistance. Clin Infect Dis 44 (2007) 886-887
31. Sinkowitz-Cochran R.L., Stein G.P., Keyserling H.L., et al., The Pediatric Prevention Network. The internet: a practical example of the use of new technology in the assessment of vancomycin use in pediatrics. Am J Infect Control 28 (2000) 459-464